Tools

LEADER 01368nam a2200385 i 4500

001 on1153935440;

003 OCoLC;

005 20200511103812.0;

006 m o d f ;

007 cr cn|||||||||;

008 200511s2018 mdu o f000 0 eng c;

035 a| (Sirsi) o1153935440;

042 a| pcc;

049 a| ERE#;

074 a| 0507-G-02 (online);

086 0 a| HE 20.3152:AN 4/2;

245 00 a| Angiogenesis inhibitors.;

264 1 a| [Bethesda, Md.] :b| U.S. Department of Health, National Institutes of Health, National Cancer Institute,c| 2018.;

300 a| 1 online resource;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Title from title screen (NCI, viewed May 11, 2020).;

500 a| "April 2, 2018.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

650 0 a| Neovascularization inhibitors.=| ^A715048;

650 0 a| Cancerx| Treatment.=| ^A13628;

710 2 a| National Cancer Institute (U.S.)e| issuing body.=| ^A287;

856 40 u| https://purl.fdlp.gov/GPO/gpo125386;

922 a| BIBCONEW;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5332482;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5332482-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 6/16/2020x| EDOCUMENTz| JERESOURCE;

Angiogenesis inhibitors.

Other author	National Cancer Institute (U.S.) issuing body.
Format	Electronic
Publication	[Bethesda, Md.] : U.S. Department of Health, National Institutes of Health, National Cancer Institute, 2018.
Description	1 online resource
Supplemental Content	https://purl.fdlp.gov/GPO/gpo125386
Subjects	Neovascularization inhibitors. Cancer--Treatment.

General note	Title from title screen (NCI, viewed May 11, 2020).
General note	"April 2, 2018."
General note	GPO Cataloging Record Distribution Program (CRDP).
GPO item number	0507-G-02 (online)
Govt. docs number	HE 20.3152:AN 4/2

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title